Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
KEY PRODUCTS
Reset all filters
01 1Noramco
Reset all filters
01 1OXYCODONE HYDROCHLORIDE DRUG SUBSTANCE
Reset all filters
01 1U.S.A
Reset all filters
01 1Active
Reset all filters
01 1Complete
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Complete
Rev. Date : 2012-12-27
Pay. Date : 2012-11-23
DMF Number : 20975
Submission : 2007-10-26
Status : Active
Type : II
20
Noramco Llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
One of their notable products is OXYCODONE HYDROCHLORIDE DRUG SUBSTANCE, with a corresponding US DMF Number 20975.
Remarkably, this DMF maintains an Active status since its submission on October 26, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 27, 2012, and payment made on November 23, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II